Company news
Sihuan Pharmaceutical Holdings Group Ltd. (HKEX:460) news
Sihuan Pharmaceutical Holdings Group Ltd. news releases on 6ix. Latest, Oct 2, 2026: Monthly Return of Equity Issuer on Movements in Securities for the month…
Press releases & updates
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
October 2, 2026
Sihuan Pharmaceutical : VOLUNTARY ANNOUNCEMENT - INSULIN ASPART 30 INJECTION DEVELOPED BY SIHUAN PHARMACEUTICAL ACHIEVED EQUIVALENT CLINICAL RESULTS IN EFFICACY AND SAFETY STUDY AS ORIGINATOR DRUG
July 30, 2021
Sihuan Pharmaceutical : VOLUNTARY ANNOUNCEMENT-ENTERING INTO STRATEGIC COOPERATION AGREEMENT BETWEEN JILIN HUISHENG BIOPHARMACEUTICAL AND PORTON PHARMA
April 28, 2021
Sihuan Pharmaceutical : VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE
April 9, 2021
Sihuan Pharmaceutical : VOLUNTARY ANNOUNCEMENT-SIHUAN PHARMACEUTICAL OBTAINED DRUG REGISTRATION APPROVAL IN RELATION TO AMBROXOL HYDROCHLORIDE INJECTION
April 1, 2021
Sihuan Pharmaceutical : VOLUNTARY ANNOUNCEMENT PROPOSED SHARE REPURCHASE UNDER THE GENERAL MANDATE
March 28, 2021
Sihuan Pharmaceutical : VOLUNTARY ANNOUNCEMENT SIHUAN PHARMACEUTICAL OBTAINED DRUG REGISTRATION APPROVAL IN RELATION TO RIVAROXABAN TABLETS
March 25, 2021
Sihuan Pharmaceutical : VOLUNTARY ANNOUNCEMENT THE GROUP'S LIRAGLUTIDE HAS COMPLETED PHASE I CLINICAL STUDY FOR INDICATION OF WEIGHT LOSS
February 25, 2021
Sihuan Pharmaceutical : VOLUNTARY ANNOUNCEMENT OFFICIAL RELEASE OF THE RESULT OF LARGE-SCALE CLINICAL TRIALS AFTER THE LAUNCH OF CINEPAZIDE MALEATE INJECTION THE DRUG TAKES STROKE TREATMENT INTO A NEW ERA WITH ITS VERIFIED EFFICACY
August 21, 2020
Sihuan Pharmaceutical : VOLUNTARY ANNOUNCEMENT - CAPITAL INJECTION BY NEW INVESTORS INTO BEIJING RUIYE DRUGS MANUFACTURE CO., LTD. (AN ASSOCIATE OF SIHUAN PHARMACEUTICAL) TO ACCELERATE CAPACITY EXPANSION
August 19, 2020
Sihuan Pharmaceutical : NOTICE OF BOARD MEETING
August 13, 2020
Sihuan Pharmaceutical : VOLUNTARY ANNOUNCEMENT - ACQUISITION OF ALL INTERESTS AND INTELLECTUAL PROPERTY RIGHTS OF PLAZOMICIN, A NEW GENERATION OF AMINOGLYCOSIDE ANTIBIOTICS IN THE GREATER CHINA REGION
February 20, 2020
Sihuan Pharmaceutical : VOLUNTARY ANNOUNCEMENT - PRODUCTION APPROVAL GRANTED FOR RIVASTIGMINE HYDROGEN TARTRATE CAPSULE, THE FIRST DRUG PASSING CONSISTENCY EVALUATION AND LEVETIRACETAM TABLET AND THE FIRST REGISTRATION APPROVAL GRANTED FOR MIDAZOLAM OROMUCOSAL SOLUTION
February 18, 2020
Sihuan Pharmaceutical : VOLUNTARY ANNOUNCEMENT - Commencement of Phase III Clinical Trial in the PRC for Self-Developed Innovative Patented Drug "Anaprazole Sodium" and Inclusion of "Huineng" into the National Reimbursement Drug List
February 13, 2020
Sihuan Pharmaceutical : VOLUNTARY ANNOUNCEMENT - SIHUAN PHARMACEUTICAL AND HETERO LABS LIMITED REACHED A FRAMEWORK COOPERATION AGREEMENT IN PHARMACEUTICAL MANUFACTURING AREA
February 11, 2020
Sihuan Pharmaceutical : has been Granted the Drug Registration Approval for Another Solid-Liquid Double Chamber Bag, and is the First Company in China that Obtained Drug Registration Approval for "Non-PVC Solid-Liquid Double Chamber Bag for Cefuroxime Sodium/Sodium Chloride Injection"
June 19, 2019